O'Neill D'Cruz

Dr. D’Cruz completed undergraduate medical training at St John’s Medical College, Bangalore, India, pediatric and neurology residencies at Rush University and Medical College of Wisconsin, respectively, and obtained an MBA at the Kenan-Flagler Business School, UNC-Chapel Hill. Dr. D’Cruz is board certified in neurology/child neurology, neurophysiology, and sleep medicine, and a Fellow of the American Academies of Neurology and Sleep Medicine. He has authored numerous publications.

Dr. D’Cruz was previously a Professor of Neurology and Pediatrics at the University of North Carolina-Chapel Hill, USA. His previous industry appointments include Medical Director, Neurology at UCB Pharma and Chief Medical Officer, Cyberonics. He currently serves on the Board of Directors of ASENT (American Society of Experimental Neuro-Therapeutics) and is the industry representative of the Pediatric Epilepsy Academic Consortium for Extrapolation (PEACE), a public-private partnership between academia, industry, and patient advocacy organizations that helped develop globally harmonized regulatory pathways based on extrapolation of anti-epileptic drug efficacy data from adults to children.

In addition to industry experience in clinical development and safety monitoring, business development, regulatory interactions, and public-private partnerships, Dr. D’Cruz has worked in the field of neurology for over twenty-five years, as a board-certified neurologist and epileptologist, clinical investigator, invited speaker at scientific and industry conferences, health policy, and patient advocate and consultant to leading pharmaceutical companies. He maintains a clinical practice in neurology targeted toward underserved regions and population segments.